AKTS
Aktis Oncology·NASDAQ
--
--(--)
--
--(--)
AKTS fundamentals
EPS
Revenue
Revenue & Expenses
AKTS has released its 2024 Q4 earnings report, with revenue of 933.00K, reflecting a YoY change of NaN%, and net profit of -12.06M, showing a YoY change of -43.29%. The Sankey diagram below clearly presents AKTS's revenue sources and cost distribution.
Key Indicators
Aktis Oncology (AKTS) key financial stats and ratios, covering profitability, financial health, and leverage.
Aktis Oncology (AKTS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aktis Oncology (AKTS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aktis Oncology (AKTS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aktis Oncology (AKTS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aktis Oncology (AKTS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Aktis Oncology next quarter?What is the revenue and EPS growth rate for Aktis Oncology year over year?What is Aktis Oncology's latest dividend and current dividend yield?What guidance did Aktis Oncology's management provide for the next earnings period?What does Aktis Oncology do and what are its main business segments?What is Aktis Oncology's gross profit margin?What were the key takeaways from Aktis Oncology’s earnings call?What factors drove the changes in Aktis Oncology's revenue and profit?
